Tokyo Tape
Sign in
← Sakai Chemical Industry

Quarterly report · Q2

4078.TEDINET S100PH2A
Period2022-04-01 → 2022-09-30
Filed2022-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥42.7bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥80.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥39.9bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥3.3bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥4.4bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥3.8bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥8.8bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.6bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥4.2bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥4.5bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥2.9bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥6.7bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.2bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥3.0bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥3.3bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥128.4bnat 2022-09-30Cons.Assets
Total assets¥123.9bnat 2022-03-31Cons.Assets
Total assets¥124.5bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥42.6bnat 2022-09-30Cons.Liabilities
Total liabilities¥41.2bnat 2022-03-31Cons.Liabilities
Net assets / equity¥85.8bnat 2022-09-30Cons.Net assets
Net assets / equity¥82.7bnat 2022-03-31Cons.Net assets
Net assets / equity¥82.3bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥11.9bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥10.8bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥11.7bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥10.5bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥11.8bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥11.2bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥6.6bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥5.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥3.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥1.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.0bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥177.482022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥68.082022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥407.062021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥188.852021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥91.632021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio63.6%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio63.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio63.2%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥860m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥860m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥1.1bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue2022-04-01 → 2022-09-30¥39.3bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue external2022-04-01 → 2022-09-30¥38.6bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥697m
jpcrp040300-q2r_E00780-000Chemicalreportable segmentsegment profit2022-04-01 → 2022-09-30¥4.2bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue2022-04-01 → 2022-09-30¥4.3bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue external2022-04-01 → 2022-09-30¥4.1bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥163m
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentsegment profit2022-04-01 → 2022-09-30¥240m
—segment totalrevenue2022-04-01 → 2022-09-30¥43.6bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥42.7bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥860m
—segment totalsegment profit2022-04-01 → 2022-09-30¥4.4bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥684m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥684m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥977m
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue2021-04-01 → 2021-09-30¥36.4bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue external2021-04-01 → 2021-09-30¥35.8bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥548m
jpcrp040300-q2r_E00780-000Chemicalreportable segmentsegment profit2021-04-01 → 2021-09-30¥5.1bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue2021-04-01 → 2021-09-30¥4.2bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue external2021-04-01 → 2021-09-30¥4.1bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥136m
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentsegment profit2021-04-01 → 2021-09-30¥233m
—segment totalrevenue2021-04-01 → 2021-09-30¥40.6bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥39.9bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥684m
—segment totalsegment profit2021-04-01 → 2021-09-30¥5.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 510
ItemContextValueUnit
Profit loss attributable to owners of parentPrior1YTDDuration3180000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration2871000000JPY
Profit lossPrior1YTDDuration3336000000JPY
Profit lossCurrentYTDDuration3023000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-233000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-156000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration-2000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration25000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration133000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration773000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-11000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-0JPY
Other comprehensive incomePrior1YTDDuration-112000000JPY
Other comprehensive incomeCurrentYTDDuration643000000JPY
Comprehensive incomePrior1YTDDuration3223000000JPY
Comprehensive incomeCurrentYTDDuration3666000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration2997000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration3282000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration225000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration384000000JPY
Income before income taxesPrior1YTDDuration4537000000JPY
Income before income taxesCurrentYTDDuration4218000000JPY
Depreciation and amortization ope cfPrior1YTDDuration2107000000JPY
Depreciation and amortization ope cfCurrentYTDDuration2191000000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration-3000000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration-6000000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration46000000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration12000000JPY
Increase decrease in net defined benefit liability ope cfPrior1YTDDuration3000000JPY
Increase decrease in net defined benefit liability ope cfCurrentYTDDuration-0JPY
Interest and dividends income ope cfPrior1YTDDuration-121000000JPY
Interest and dividends income ope cfCurrentYTDDuration-92000000JPY
Interest expenses ope cfPrior1YTDDuration37000000JPY
Interest expenses ope cfCurrentYTDDuration36000000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration-173000000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration1064000000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-509000000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-4860000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration821000000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration533000000JPY
Other net ope cfPrior1YTDDuration-689000000JPY
Other net ope cfCurrentYTDDuration-1526000000JPY
Subtotal ope cfPrior1YTDDuration6057000000JPY
Subtotal ope cfCurrentYTDDuration1570000000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration121000000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration92000000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration-37000000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-38000000JPY
Proceeds from subsidy ope cfPrior1YTDDuration－JPY
Proceeds from subsidy ope cfCurrentYTDDuration771000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass